Part Number : NDC00013-2001-19 | Manufacturer : Erbamont Inc | ||
NSN : 6505-01-101-8922 (6505011018922) | |||
Item Name : Pancrelipase Tablets Usp | CAGE Code : 58750 | ||
NIIN : 01-101-8922 (011018922) | |||
INC Code : 34464 | |||
NCB Code : 01 | Country : USA | ||
Alternate P/N: NDC00013200119 |
Thank you for taking an interest in part number NDC00013-2001-19, that of which is listed with the description Pancrelipase Tablets Usp; Manufactured by Erbamont Inc and listed alongside the NSN 6505011018922, part number NDC00013-2001-19 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
Part Number : NDC00013-2001-19 | Manufacturer : Erbamont Inc | ||
NSN Number : 6505-01-101-8922 (6505011018922) | |||
Item Name : Pancrelipase Tablets Usp | CAGE Code : 58750 | ||
NIIN : 011018922 |
Thank you for taking an interest in part number NDC00013-2001-19, that of which is listed with the description Pancrelipase Tablets Usp; Manufactured by Erbamont Inc and listed alongside the NSN 6505011018922, part number NDC00013-2001-19 is available for immediate purchase on our website. As such, to learn more about this offering while receiving a competitive quote for your comparisons, be sure to fill out and submit the RFQ form presented on this page. Within 15 minutes of us receiving and reviewing a completed form, a member of our staff will contact you to present a tailored solution for your comparisons.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-101-8922 Item PartTypeName: PANCRELIPASE TABLETS | 6505 | 011018922 | P | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
U | U | |||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
ILOZYME | 5 | 1 | 5 |
MRC | Criteria | Characteristic |
---|---|---|
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 30000.000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 11000.000 USP UNITS LIPASE ACTIVE INGREDIENT AND 30000.000 USP UNITS PROTEASE ACTIVE INGREDIENT |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 250.000 TABLETS |
CSGS | ADMINISTRATION | ORAL |
MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
We hope that you will visit us again the next time you need board-level components, aviation and aerospace parts, and more. Allow us to serve as your strategic purchasing partner.
Request for Quote